Cartesian Therapeutics, Inc.
RNAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001453687
No open-market purchases or sales by Cartesian Therapeutics, Inc. insiders were filed in the last 90 days; 94 institutions reported holding it in 13F filings for Q2 2026, worth $90.4M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Cartesian Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 68 | 2 | 72 | +6 |
| Shares | 6.67M | 72.3K | 6.58M | −9.88K (−0.1%) |
| Value | $119.5M | $1.29M | $86.7M | −$31.5M (−26.6%) |
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 38,605 | $508.8K | 0.00% |
| Nuveen, LLC | 27,869 | $367.3K | 0.00% |
| Gsa Capital Partners LLP | 16,791 | $221.0K | 0.02% |
| Susquehanna International Group, LLP | 12,460 | $164.2K | 0.00% |
| Virtus Investment Advisers, Inc. | 8,160 | $107.5K | 0.03% |
| Quest Partners LLC | 7,191 | $94.8K | 0.01% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 712 | $9.38K | 0.00% |
| Coldstream Capital Management Inc | 29 | $383 | 0.00% |
| EverSource Wealth Advisors, LLC | 12 | $158 | 0.00% |
| GAMMA Investing LLC | 9 | $119 | 0.00% |
| True Wealth Design, LLC | 2 | $27 | 0.00% |
| Smallwood Wealth Investment Management, LLC | 350 | $0 | 0.00% |
| Global Financial Private Client, LLC | 1,000 | $0 | 0.00% |
Sold out (7)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Boothbay Fund Management, LLC | 14,491 | $259.5K |
| Renaissance Technologies LLC | 13,800 | $247.2K |
| Squarepoint Ops LLC | 10,652 | $190.8K |
| Johnson Financial Group, Inc. | 4,618 | $89.2K |
| Virtus ETF Advisers LLC | 3,533 | $63.3K |
| Hall Laurie J Trustee | 1,759 | $32.0K |
| Truvestments Capital LLC | 10 | $179 |
Not filed for Q1 2025 yet (2)
Institutions that held Cartesian Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 72,099 | $1.29M |
| WR Wealth Planners, LLC | 233 | $591 |